Abstract
Dengue is one of the most important arboviral diseases recorded in the
world. Dengue, a public health problem in tropical and subtropical countries, is spread
by female Aedes mosquito bites. Among Aedes mosquitoes, Aedesaegypti is the
primary vector and Aedesalbopictus is the less infective secondary vector [1]. Dengue
hemorrhagic fever (DHF) is a severe form of the disease, that causes differential
expression of the TLRs in dendritic cells (DCs). TLR3 and TLR9 in DCs of patients
with early onset of dengue fever were unregulated, whereas in severe cases, poor
expression of TLR3 and TLR9 is observed [2]. This kind of alteration in the TLR
expression during dengue may alter the clinical manifestation of the disease. However,
this can be considered for further research on therapeutics.
Related Journals
Current Dentistry
Current Psychopharmacology
Recent Advances in Anti-Infective Drug Discovery
Anti-Infective Agents
Adolescent Psychiatry
Current Aging Science
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current HIV Research
Current Neurovascular Research
Current Respiratory Medicine Reviews
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents